RWA Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68M Buy
5,082
+12
+0.2% +$6.73K 0.03% 234
2026
Q1
$2.85M Buy
5,070
+1
+0% +$641 0.03% 218
2025
Q4
$3.43M Buy
5,069
+6
+0.1% +$4.09K 0.04% 203
2025
Q3
$3.23M Hold
5,063
0.04% 216
2025
Q2
$2.72M Sell
5,063
-159
-3% -$76K 0.03% 216
2025
Q1
$2.19M Sell
5,222
-30
-0.6% -$13K 0.03% 235
2024
Q4
$2.17M Sell
5,252
-50
-0.9% -$21.9K 0.03% 240
2024
Q3
$2.68M Buy
5,302
+136
+3% +$66.1K 0.03% 219
2024
Q2
$2.52M Hold
5,166
0.03% 210
2024
Q1
$2.79M Sell
5,166
-359
-6% -$196K 0.04% 201
2023
Q4
$3.07M Buy
+5,525
New +$2.59M 0.04% 185

Other funds holding IDXX

RWA Wealth Partners's IDXX Position: Q2 2026 in Review

RWA Wealth Partners increased its Idexx Laboratories (IDXX) stake by 0.24% in Q2 2026, buying an estimated $6.73K and bringing the position to 5,082 shares worth $2.68M. The position accounts for 0.03% of the portfolio, ranked #234.

RWA Wealth Partners first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.43M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • RWA Wealth Partners held 5,082 shares of Idexx Laboratories worth $2.68M as of Q2 2026.
  • RWA Wealth Partners bought 12 Idexx Laboratories shares in Q2 2026, an estimated $6.73K.
  • Idexx Laboratories made up 0.03% of RWA Wealth Partners's portfolio in Q2 2026, its #234 holding.
  • RWA Wealth Partners first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • RWA Wealth Partners's Idexx Laboratories position peaked at $3.43M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.